Skip to main content
Premium Trial:

Request an Annual Quote

Carl Peck

Premium

Population-based pharmacokinetic simulation firm Simcyp has appointed Carl Peck to its scientific advisory board. Peck is the founding director of the Center for Drug Development Science at the University of California, San Francisco; a former director of the US Food and Drug Administration’s Center for Drug Evaluation and Research, and a former assistant surgeon general.

Filed under

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.